Status:
UNKNOWN
A Feasibility Study of the Bone@BC App Version 3.0
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
50-70 years
Phase:
NA
Brief Summary
Introduction Due to improvements in diagnostics and treatments, the 5-year survival for patients with breast cancer is 80-90% after initial diagnosis. During treatments, patients typically have consul...
Detailed Description
AIM The aim is to investigate the feasibility and user satisfaction of an app Bone@BC version 3.0 and if the app Bone@BC can enhance self-efficacy and investigate user statistics and traffic in the ap...
Eligibility Criteria
Inclusion
- Postmenopausal women
- Age 50-70 years
- Danish speaking
- Diagnosed with EBC, stage I-III
- Eligible to receive (neo-) adjuvant chemotherapy or adjuvant treatments
- Access to an E-mail address
- Access to smart mobile electronic devices connected to the internet
- Willingness to have the app installed on the smart mobile electronic devices
- Ability to work with the app
Exclusion
- Prior malignancy
- Pre-existing type 2 diabetes or other metabolic diseases
- Withdrawn or not given a consent form
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05367830
Start Date
December 1 2022
End Date
October 30 2024
Last Update
October 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.